Clinical Trials Directory

Trials / Unknown

UnknownNCT04192305

Impact of LPV During OFA on Postoperative Oxygen Saturation.

Observational Study Evaluating the Impact of Lung Protective Ventilation (LPV) During Opioid Free Anesthesia (OFA) on Postoperative Oxygen Saturation.

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
AZ Sint-Jan AV · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Observational study comparing patients with lung protective ventilation (LPV) following the consensus guidelines by Young C with patients getting routine lung ventilation, both during opioid free anesthesia (OFA).

Detailed description

The paper by C Young et al describes the essential steps in protecting the lungs and preventing post operative pulmonary complications (PPC) like alveolar collapse. Alveolar collapse can be measured by oxygen saturation drop when no oxygen therapy is given, when full neuromuscular block (NMB) reversal and no opioid is given intra and postoperative. LPV means: tidal volume of 6 ml/kg, inspiratory-expiratory (I/E) ratio of 1/1, positive end expiratory pressure (PEEP) minimum 5 cmH20 and higher during laparoscopy in obese patients, Inspiratory oxygen concentration (FIO2) max 80% during induction and max 40 % during maintenance and extubation. Extubation in an awake, full NMB reversed patient getting no opioids while giving continuous positive airway pressure (CPAP) during withdrawal of the tube. Lung recruitment maneuver (LRM) when lung compliance decreases below 40 milliliter per centimeter water. (ml/cmH2O)

Conditions

Interventions

TypeNameDescription
PROCEDURELPVLPV means tidal volume of 6 ml/kg, inspiratory-expiratory (I/E) ratio of 1/1, positive end expiratory pressure (PEEP) minimum 5 cmH20 and higher during laparoscopy in obese patients, Inspiratory oxygen concentration (FIO2) 40 % during maintenance and extubation while also giving CPAP. Lung recruitment maneuver (LRM) when lung compliance decreases below 40 ml/cmH2O.
PROCEDUREroutine LVGive volume en frequency as required by end tidal carbon dioxide, PEEP and LRM only when saturation drops intra operative, no requirement to use low FIO2 and CPAP during extubation.

Timeline

Start date
2019-12-01
Primary completion
2020-12-01
Completion
2021-12-01
First posted
2019-12-10
Last updated
2019-12-10

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04192305. Inclusion in this directory is not an endorsement.